Skip to main content

Table 1 Demographic characteristics

From: Clinical characteristics and prognosis of patients with isolated thrombotic vs. obstetric antiphospholipid syndrome: a prospective cohort study

 

IoAPS

(n = 44)

ItAPS

(n = 39)

tAPS+oAPS

(n = 9)

P value

All groups

P value

IoAPS vs. ItAPS

Age (years), mean ± SD

33.16 ± 4.22

41.92 ± 11.97

35.22 ± 3.82

0.000

0.000

BMI (kg/m2), mean ± SD

22.84 ± 3.21

24.60 ± 4.20

24.61 ± 2.69

0.086

0.024

Duration, months median (Q1, Q3)

48.50 (36.00, 77.00)

51.00 (22.00, 93.00)

41.00 (15.00, 61.00)

0.657

0.404

Smoking history, n (%)

1 (2.27)

1 (2.56)

0

1.000

1.000

Cardiovascular risk factors, n (%)

3 (6.82)

16 (41.03)

3 (33.33)

0.002

0.000

 Coronary heart disease

0 (0)

3 (7.69)

0

0.219

0.099

 Hypertension

1 (2.27)

6 (15.38)

2 (22.22)

0.028

0.048

 Obesity (BMI > 30 kg/m2)

2 (4.55)

8 (20.51)

0

0.048

0.040

 Diabetes mellitus

0 (0)

0 (0)

0

–

–

 Hyperlipidemia

0 (0)

3 (7.69)

1 (11.11)

0.107

0.099

Complications, n (%)

12 (27.27)

20 (51.28)

4 (44.44)

0.079

0.041

 Kidney disease

2 (4.55)

3 (7.69)

0

0.799

0.662

 Thrombocytopenia

9 (20.45)

17 (43.59)

4 (44.44)

0.056

0.033

 Non-stroke CNS manifestations

1 (2.27)

3 (7.69)

0

0.573

0.337

 Valvular heart disease

4 (9.09)

3 (7.69)

1 (11.11)

1.000

1.000

 aGAPSS median (Q1, Q3)

4 (4, 12)

10 (4, 13)

13 (6, 15)

0.001

0.001

  1. BMI, body mass index; cardiovascular risk factors and complications positive, patients with at least one positive subgroup symptom; CNS, central nervous system; aGAPSS, adjusted Global Anti-Phospholipid Syndrome Score